Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 2/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13276324 | 1.00 | CYP2D6 (0.36) | CYP2D6METAP2METAP1MCL1PKM | |
| SCHEMBL13276323 | 1.00 | CYP2D6 (0.36) | CYP2D6METAP2METAP1MCL1PKM | |
| SCHEMBL342150 | 0.82 | — | — | |
| SCHEMBL10021591 | 0.81 | CES1 (0.37) | CYP2D6METAP2METAP1PKMALDH1A1 | |
| SCHEMBL13276170 | 0.77 | LMNA (0.38) | METAP2RAB9AALDH1A1 | |
| SCHEMBL10087038 | 0.77 | LMNA (0.38) | METAP2RAB9AALDH1A1 | |
| SCHEMBL13276169 | 0.77 | LMNA (0.38) | METAP2RAB9AALDH1A1 | |
| SCHEMBL21436312 | 0.76 | MEN1 (0.48) | RAB9AALDH1A1 | |
| SCHEMBL15113004 | 0.74 | MAPT (0.47) | RAB9AALDH1A1 | |
| SCHEMBL14003457 | 0.73 | LMNA (0.38) | METAP2RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250108658-A1 | INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS | Prism Inks, Inc. (US) | 2025-04-03 | — | — | US | disclosed |
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | HFC PRESTIGE SERVICE GERMINY GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-4171500-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | Wella Germany GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| US-11324688-B2 | Bicomponent composition | WELLA INTERNATIONAL OPERATIONS SWI (CH) | 2022-05-10 | — | — | US | disclosed |
| US-20220054392-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2022-02-24 | — | — | US | disclosed |
| US-20220016017-A1 | COLOR COATINGS WITH DOWNSTREAM FEATURES | HFC PRESTIGE SERVICE GERMANY GMBH (DE) | 2022-01-20 | — | — | US | disclosed |
| WO-2022002983-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | HFC PRESTIGE SERVICE GERMANY GMBH (DE) | 2022-01-06 | — | — | WO | disclosed |
| EP-3890683-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-10-13 | — | — | EP | disclosed |
| US-20210290519-A1 | MULTICOMPONENT SILICONE COMPOSITION | WELLA INT OPERATIONS SWITZERLAND SARL (CH) | 2021-09-23 | — | — | US | disclosed |
| US-20210290518-A1 | MULTICOMPONENT COMPOSITION | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2021-09-23 | — | — | US | disclosed |
| US-20210145726-A1 | BICOMPONENT COMPOSITION | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2021-05-20 | — | — | US | disclosed |
| EP-3817710-A1 | MULTICOMPONENT SILICONE COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-05-12 | — | — | EP | disclosed |
| EP-3817825-A1 | MULTICOMPONENT PUR COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-05-12 | — | — | EP | disclosed |
| EP-3787753-A1 | MULTICOMPONENT COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-03-10 | — | — | EP | disclosed |
| EP-3773922-A1 | BICOMPONENT COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020114647-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2020-06-11 | — | — | WO | disclosed |
| WO-2020007510-A1 | MULTICOMPONENT PUR COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2020-01-09 | — | — | WO | disclosed |
| WO-2020007511-A1 | MULTICOMPONENT SILICONE COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2020-01-09 | — | — | WO | disclosed |
| WO-2019192916-A1 | BICOMPONENT COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2019-10-10 | — | — | WO | disclosed |
| US-20120141398-A1 | HAIR DYE CONTAINING ONE OR MORE EDIBLE OR COSMETIC COLORS | CHUANG KUO SHENG (TW) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016017-A1 | COLOR COATINGS WITH DOWNSTREAM FEATURES | KRT18, ITGA5, FLNA | CYP2D6 3379/4885METAP2 2420/4885METAP1 3578/4885 |
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | KRT18, MKI67, IK | CYP2D6 1399/4885METAP2 2249/4885METAP1 2625/4885 |
| US-20210290519-A1 | MULTICOMPONENT SILICONE COMPOSITION | CUTA, CD99, PLOD3 | CYP2D6 2433/4885METAP2 630/4885METAP1 1158/4885 |
| US-20220054392-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | KRT18, PRKDC, VIM | CYP2D6 4148/4885METAP2 3199/4885METAP1 3310/4885 |
| US-11324688-B2 | Bicomponent composition | KRT18, EXOSC10, EXOSC9 | CYP2D6 3019/4885METAP2 3228/4885METAP1 3957/4885 |
| US-20210290518-A1 | MULTICOMPONENT COMPOSITION | KRT18, INCENP, IK | CYP2D6 3799/4885METAP2 1615/4885METAP1 2476/4885 |
| US-20210145726-A1 | BICOMPONENT COMPOSITION | KRT18, EXOSC10, EXOSC9 | CYP2D6 3019/4885METAP2 3228/4885METAP1 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.